Manufacturing strategies for plasmid DNA in advanced therapy applications

Webinar On Demand

As the cell and gene therapy market continues to experience rapid investment and increased IND submissions, new questions arise regarding appropriate application of regulatory guidelines and manufacturing strategies for the critical raw materials used in the development of these ground-breaking treatments. New commercial applications for plasmid DNA in particular have highlighted the need for increased manufacturing capacity and clarity on best practices for implementation of GMP principles. Watch this webinar for insights from technical, quality, and regulatory experts to help optimize your manufacturing strategy for plasmid DNA, including:

  • Update on cell and gene therapy market trends and approvals
  • Latest regulatory recommendations on use of GMP raw materials in advanced therapy manufacturing processes
  • Guidance on application of GMP principles for plasmid manufacturing using a risk-based approach
  • Suggestions for cell and gene therapy innovators to accelerate timelines and mitigate risk